06-Jan-16 A new study in the Lancet’s special series on Antimicrobial Resistance shows that only 12.5% of India’s under-five children with suspected pneumonia are actually receiving treatment, resulting in 210,000 deaths every year. “Access to effective antimicrobials: A worldwide challenge” goes on to conclude that India could avert 80.7% of these deaths by universalizing access to antibiotics. [image: The Tribune]

30-Dec-15 The healthcare market in India was worth close USD100 bn in 2015 and is expected to touch USD280 bn by 2020, with a CAGR of 23%. India's healthtech space has grown steadily in 2015 both in terms of funding and deal numbers. Preventive medicine is likely to see more activity in 2016 and rural India is set to emerge as a demand source. [image: Your Story]

27-Dec-15 Japanese health monitor maker Omron Healthcare is looking at more than doubling its revenues in India to USD40 mn by 2018/19, on the back of sales network expansion. The company, which is expecting sales of USD19 mn this year, is also open to the idea of opening a factory in India depending on the demand of its products. [image: Ormon Healthcare].

16-Dec-15 Singapore-based Parkway Pantai, one of Asia's largest healthcare providers, is planning huge healthcare capacities in India, challenging leaders like Apollo and Fortis. Parkway, owned by the Malaysian sovereign fund-backed IHH Healthcare, is planning to add up to 5,000 beds in the next two years, half of this in India, said Dr Tan See Leng, managing director of Parkway and IHH. [image: Business Today]

15-Dec-15 Despite recording gains in recent years, India continues to lag several health indicators such as mortality rates and malnutrition. A paper in The Lancet identifies seven structural problems: 1. A weak primary healthcare; 2. Unequally distributed human resources; 3. Large unregulated private sector; 4. Low public spending; 5. Fragmented information systems; 6. Irrational drug use and spiralling cost; 7. Weak governance and accountability. [image: Hindustan Times]